Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950123-07-007140
Filing Date
2007-05-10
Accepted
2007-05-09 21:03:41
Documents
7
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K y31819ae10vkza.htm 10-K/A 495159
2 EX-23.1: CONSENT OF MCGLADREY & PULLEN, LLP y31819aexv23w1.htm EX-23.1 2755
3 EX-23.2: CONSENT OF PRICEWATERHOUSECOOPERS LLP y31819aexv23w2.htm EX-23.2 1182
4 EX-31.1: CERTIFICATION y31819aexv31w1.htm EX-31.1 8471
5 EX-31.2: CERTIFICATION y31819aexv31w2.htm EX-31.2 8042
6 EX-32.1: CERTIFICATION y31819aexv32w1.htm EX-32.1 4337
7 EX-32.2: CERTIFICATION y31819aexv32w2.htm EX-32.2 4305
  Complete submission text file 0000950123-07-007140.txt   525742
Mailing Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617-349-4500
JAVELIN PHARMACEUTICALS, INC (Filer) CIK: 0000050710 (see all company filings)

EIN.: 880471759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-32949 | Film No.: 07834353
SIC: 2834 Pharmaceutical Preparations